Portrait of Scanlon, Mary Gay

Scanlon, Mary Gay

U.S. Representative PA-5 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
8
Buys / sells
0% / 75%
Last trade
May 23, 2023
Last filing
Jun 5, 2023

Latest disclosed trades

Latest 8 of 8
Ticker Type Traded
EXC Sell May 23, 2023
CEG Sell May 23, 2023
EXC Exchange Feb 4, 2022
CTVA Sell Feb 12, 2021
DOW Sell Feb 12, 2021
IFF Sell Feb 12, 2021
ORCL Sell Feb 12, 2021
DD Exchange Feb 1, 2021

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Scanlon, Mary Gay stock trade activity

FilingIQ has indexed 8 congressional stock trade disclosures for Scanlon, Mary Gay. The most recent disclosed transaction is dated May 23, 2023.

Across the full history, 0 purchases and 6 sales have been disclosed under the STOCK Act.

Top tickers traded by Scanlon, Mary Gay

Frequently asked

How many stock trades has Scanlon, Mary Gay disclosed?
FilingIQ tracks 8 Periodic Transaction Report disclosures for Scanlon, Mary Gay, with the most recent dated May 23, 2023. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Scanlon, Mary Gay a net buyer or net seller?
Across the disclosed trade history, 0 (0%) were purchases and 6 (75%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Scanlon, Mary Gay come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.